YDES
YD Bio Limited Ordinary Shares
NASDAQ · Healthcare · Biotechnology · TW
$3.54
−3.54%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
18.5%
Return on equity
-100.8%
Return on assets
8.6%
Return on invested capital
0.00x
Asset turnover
-$1.2M
Cash from operations
$0.00
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Dec 1, 2025